Chemical activators of Olr25 can exert their influence through a variety of mechanisms, primarily involving the elevation of intracellular cyclic AMP (cAMP) levels, which in turn can activate protein kinase A (PKA), a key regulator in many cellular processes. Forskolin, a known direct activator of adenylyl cyclase, can lead to an increase in intracellular cAMP levels, setting off a cascade that can activate PKA, which may then facilitate the activation of Olr25. Similarly, Isoproterenol, a synthetic agonist of beta-adrenergic receptors, elevates cAMP levels, possibly leading to the same PKA-mediated activation pathway for Olr25. Prostaglandin E2 (PGE2) works through its interaction with EP receptors, which also elevate cAMP and thus can lead to Olr25 activation via PKA. Histamine, through its action on H2 receptors, and Dopamine, through D1-like receptors, both can raise cAMP levels, suggesting a possible PKA-mediated pathway leading to the activation of Olr25.
Furthermore, Adenosine, by interacting with A2 receptors, and Glucagon, through its own receptor, can elevate cAMP levels, suggesting a similar mechanism for Olr25 activation. Cholera toxin, by modifying the Gs alpha subunit, leads to sustained activation of adenylyl cyclase, producing increased cAMP and subsequent PKA activation, which can activate Olr25. Vardenafil and IBMX, both phosphodiesterase inhibitors, prevent the degradation of cAMP, thereby maintaining PKA activation status, which is a possible pathway for Olr25 activation. PACAP, by activating PAC1 receptors, leads to increased cAMP levels and thus can activate PKA, providing another avenue for the activation of Olr25. Lastly, Epinephrine, which also acts on beta-adrenergic receptors, increases cAMP and hence can activate PKA, suggesting yet another pathway through which Olr25 can be activated. These chemicals, through their varied interactions with receptors and enzymes that influence cAMP and PKA signaling, delineate multiple avenues through which Olr25 can be functionally activated.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Acts on beta-adrenergic receptors to elevate cAMP, which can activate PKA and potentially lead to Olr25 activation. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Binds to EP receptors that can increase cAMP production, potentially leading to PKA activation and subsequent Olr25 activation. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
Binds to H2 receptors which can increase cAMP levels, potentially leading to PKA activation that could activate Olr25. | ||||||
Dopamine | 51-61-6 | sc-507336 | 1 g | $290.00 | ||
Interacts with D1-like receptors that can increase cAMP, potentially resulting in PKA activation, which may activate Olr25. | ||||||
Adenosine | 58-61-7 | sc-291838 sc-291838A sc-291838B sc-291838C sc-291838D sc-291838E sc-291838F | 1 g 5 g 100 g 250 g 1 kg 5 kg 10 kg | $34.00 $48.00 $300.00 $572.00 $1040.00 $2601.00 $4682.00 | 1 | |
Interacts with A2 receptors, potentially increasing cAMP and leading to PKA activation, which may result in Olr25 activation. | ||||||
Vardenafil | 224785-90-4 | sc-362054 sc-362054A sc-362054B | 100 mg 1 g 50 g | $526.00 $735.00 $16653.00 | 7 | |
Inhibits PDE5, preventing cGMP and potentially cAMP degradation, which can maintain PKA activation and lead to Olr25 activation. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Non-selective inhibitor of phosphodiesterases, preventing cAMP degradation and potentially maintaining PKA activation, leading to Olr25 activation. | ||||||
PACAP(6-38) | 137061-48-4 | sc-391136 sc-391136A | 500 µg 1 mg | $540.00 $932.00 | ||
Activates PAC1 receptors, potentially increasing cAMP and leading to PKA activation, which could result in Olr25 activation. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Acts on beta-adrenergic receptors to increase cAMP, which can activate PKA and potentially lead to Olr25 activation. | ||||||